Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: MGNX -- MacroGenics

03 Aug 2017 02:42 PM <--

21 Aug 2014 11:19 AM

25 Nov 2013 02:36 PM

Return to MGNX -- MacroGenics

CD123-related abstract (preclinical) coming up at ASH, so maybe it's time for a thread. DART is a very old concept.... I was one of the first to try it, but the original concept came from Dartmouth and served as the foundation science for Medarex.

MGD006, Servier has right to license for some geographies.....

ash.confex.com

One more ASH abstract, not from MGNX.......

ash.confex.com

Pointer to the pipeline chart, website.....

macrogenics.com

Go!